title: [Systemic inflammatory reaction and indices of the organ hepatic dysfunction in patients with abdominal sepsis].
abstract: In 26 patients in complex of treatment of abdominal sepsis there was applied a 1.5% solution of reamberin intravenously in 400 ml dose during 5 days. The results of treatment were estimated, studying indices of systemic inflammatory reaction (SIR) and hepatic tests. Reamberin application have promoted rapid normalization of the parameters studied. The authors consider, that efficacy of reamberin is caused not only by positive impact on the SIR course, but by hepatoprotective action of the preparation as well.
authors.forename: N A
authors.initials: NA
authors.lastname: Veliev
authors.forename: V F
authors.initials: VF
authors.lastname: Ismailov
mesh_terms: D000005:Abdomen / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D007275:Injections, Intravenous; D016753:Interleukin-10 / Q000276:immunology; D015850:Interleukin-6 / Q000276:immunology; D008099:Liver / Q000187:drug effects* / Q000276:immunology / Q000503:physiopathology; D008111:Liver Function Tests; D008536:Meglumine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009102:Multiple Organ Failure / Q000209:etiology / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control*; D018805:Sepsis / Q000209:etiology* / Q000276:immunology / Q000503:physiopathology / Q000601:surgery; D013386:Succinates / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D015850:Interleukin-6; C549374:Reamberin; D013386:Succinates; D016753:Interleukin-10; D008536:Meglumine